337 related articles for article (PubMed ID: 10509036)
1. In vitro and in vivo effects of desmopressin on platelet function.
Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
[TBL] [Abstract][Full Text] [Related]
2. Desmopressin stimulates the expression of P-selectin on human platelets in vitro.
Wun T; Paglieroni TG; Lachant NA
J Lab Clin Med; 1995 Oct; 126(4):401-9. PubMed ID: 7561450
[TBL] [Abstract][Full Text] [Related]
3. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
[TBL] [Abstract][Full Text] [Related]
4. Platelet aggregation at high shear is impaired in patients with congenital defects of platelet secretion and is corrected by DDAVP: correlation with the bleeding time.
Cattaneo M; Pareti FI; Zighetti M; Lecchi A; Lombardi R; Mannucci PM
J Lab Clin Med; 1995 Apr; 125(4):540-7. PubMed ID: 7706911
[TBL] [Abstract][Full Text] [Related]
5. [Effect of desmopressin (DDAVP) on blood platelet parameters in vivo and in vitro].
Kätzel R; Dietzel H; Selle B; Taube C
Z Gesamte Inn Med; 1992 Jul; 47(7):303-7. PubMed ID: 1496839
[TBL] [Abstract][Full Text] [Related]
6. Uremic plasma after infusion of desmopressin (DDAVP) improves the interaction of normal platelets with vessel subendothelium.
Escolar G; Cases A; Monteagudo J; Garrido M; Lopez J; Ordinas A; Revert L; Castillo R
J Lab Clin Med; 1989 Jul; 114(1):36-42. PubMed ID: 2738447
[TBL] [Abstract][Full Text] [Related]
7. Desmopressin (DDAVP) improves recruitment of activated platelets to collagen but simultaneously increases platelet endothelial interactions in vitro.
Calmer S; Ferkau A; Larmann J; Johanning K; Czaja E; Hagl C; Echtermeyer F; Goudeva L; Heuft HG; Theilmeier G
Platelets; 2014; 25(1):8-15. PubMed ID: 23534885
[TBL] [Abstract][Full Text] [Related]
8. Laboratory response to intranasal desmopressin in women with menorrhagia and platelet dysfunction.
Rose SS; Faiz A; Miller CH; Saidi P; Philipp CS
Haemophilia; 2008 May; 14(3):571-8. PubMed ID: 18312366
[TBL] [Abstract][Full Text] [Related]
9. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Porta C; Maiolo A; Tua A; Grignani G
Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
[TBL] [Abstract][Full Text] [Related]
10. [Utility of desmopressin in 4 cases of thrombocytopathies associated with giant platelets].
Martínez-Murillo C; Quintana-González S; Ambriz-Fernández R; Arzate-Hernández G; Gutiérrez-Romero M; Gaminio-Gómez E
Rev Invest Clin; 1997; 49(4):281-6. PubMed ID: 9707993
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial.
Rao AK; Ghosh S; Sun L; Yang X; Disa J; Pickens P; Polansky M
Thromb Haemost; 1995 Oct; 74(4):1071-8. PubMed ID: 8560416
[TBL] [Abstract][Full Text] [Related]
12. A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery.
Weber CF; Dietrich W; Spannagl M; Hofstetter C; Jámbor C
Anesth Analg; 2010 Mar; 110(3):702-7. PubMed ID: 20042444
[TBL] [Abstract][Full Text] [Related]
13. 1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia.
Casonato A; Sartori MT; de Marco L; Girolami A
Thromb Haemost; 1990 Aug; 64(1):117-20. PubMed ID: 2274916
[TBL] [Abstract][Full Text] [Related]
14. The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time.
Wadanoli M; Sako D; Shaw GD; Schaub RG; Wang Q; Tchernychev B; Xu J; Porter TJ; Huang Q
Thromb Haemost; 2007 Aug; 98(2):397-405. PubMed ID: 17721623
[TBL] [Abstract][Full Text] [Related]
15. Effect of desmopressin (DDAVP) on platelet membrane glycoprotein expression in patients with von Willebrand's disease.
Gordz S; Mrowietz C; Pindur G; Park JW; Jung F
Clin Hemorheol Microcirc; 2005; 32(2):83-7. PubMed ID: 15764817
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1-desamino-8-D-arginine vasopressin (DDAVP) on human platelets.
Yang X; Disa J; Rao AK
Thromb Res; 1990 Sep; 59(5):809-18. PubMed ID: 2237837
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of desmopressin effect on primary haemostasis in pediatric patients with aspirin-like defect as hereditary thrombocytopathy.
Tauer JT; Gneuss A; Lohse JE; Jürgens T; Knöfler R
Klin Padiatr; 2011 May; 223(3):169-72. PubMed ID: 21509710
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
Hanebutt FL; Rolf N; Loesel A; Kuhlisch E; Siegert G; Knoefler R
Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
[TBL] [Abstract][Full Text] [Related]
19. Patients with prolonged bleeding time of undefined etiology, and their response to desmopressin.
Kim HC; Salva K; Fallot PL; Karp GI; Eisele J; Matts L; Heller I; Saidi P
Thromb Haemost; 1988 Apr; 59(2):221-4. PubMed ID: 3388295
[TBL] [Abstract][Full Text] [Related]
20. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]